Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02703909 · ClinicalTrials.gov registry record · Phase 4
Surgical Conditions During Laparoscopic Bariatric Surgery
A Phase 4 study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Phase 4
- Development phase
- 144
- Enrollment target
NCT02703909 is a Phase 4 study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 144 participants.
The verdict
NCT02703909, a Phase 4 study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 144 participants
- Enrollment target
Study Summary
Obesity affects more than 78 million adults in the United States and it is estimated that 35% of the US population is obese. Currently, more than 179,000 bariatric procedures are performed in the US each year with the majority of these surgeries using laparoscopic techniques. Surgeons often request deep neuromuscular blockade (NMB) during surgery, but there is no evidence that a deep NMB improves surgical conditions and that the surgeons can discriminate between a moderate and deep NMB. There is also evidence that maintaining low insufflation pressures during laparoscopic surgery may decrease postoperative pain. The goal of this prospective, randomized, assessor-blinded controlled trial is to test the hypothesis that deep NMB provides optimal surgical conditions during laparoscopic bariatric surgery in the morbidly obese patient. It will also determine if deep NMB allows the surgeon to utilize lower insufflation pressure and decreases postoperative pain requirements after laparoscopic bariatric surgery.
Interventions
- DRUG Rocuronium
- DEVICE Insufflation pressure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02703909
The ClinicalTrials.gov registry entry for NCT02703909 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Rocuronium is the first listed.
NCT02703909 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02703909 about?
NCT02703909 is a clinical study titled "Surgical Conditions During Laparoscopic Bariatric Surgery". Obesity affects more than 78 million adults in the United States and it is estimated that 35% of the US population is obese. Currently, more than 179,000 bariatric procedures are performed in the US each year with the majority of these surgeries using laparoscopic techniques. Surgeons often request ...
What is the current status of trial NCT02703909?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 144 participants. The study started on 2016-05. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02703909?
The interventions under investigation include: Rocuronium (DRUG), Insufflation pressure (DEVICE).
Who is sponsoring clinical trial NCT02703909?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.